Ulisse Biomed S.p.A. (BIT:UBM)
 1.020
 +0.020 (2.00%)
  Nov 3, 2025, 2:38 PM CET
Ulisse Biomed Revenue
Ulisse Biomed had revenue of 528.79K EUR in the half year ending June 30, 2025, with 3,176.49% growth. This brings the company's revenue in the last twelve months to 925.87K, up 119.96% year-over-year. In the year 2024, Ulisse Biomed had annual revenue of 767.93K with 1,059.87% growth.
Revenue (ttm) 
 925.87K
Revenue Growth 
 +119.96%
P/S Ratio 
 26.84
Revenue / Employee 
 51.44K
Employees 
 22
Market Cap 
24.85M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 767.93K | 701.72K | 1,059.87% | 
| Dec 31, 2023 | 66.21K | -72.23K | -52.17% | 
| Dec 31, 2022 | 138.44K | -142.00K | -50.64% | 
| Dec 31, 2021 | 280.44K | -325.06K | -53.68% | 
| Dec 31, 2020 | 605.50K | 594.63K | 5,469.84% | 
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | 
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue | 
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.48B | 
| Amplifon | 2.41B | 
| DiaSorin | 1.22B | 
| Safilo Group | 998.89M | 
| EL.En. | 579.71M | 
| Svas Biosana | 134.95M | 
| Pharmanutra | 122.25M | 
| Philogen | 84.66M |